You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
萬泰生物(603392.SH):凍幹水痘減毒活疫苗啟動III期臨牀試驗並完成首例受試者入組
格隆匯 06-19 15:42

格隆匯6月19日丨萬泰生物(603392.SH)公佈,公司的凍幹水痘減毒活疫苗(VZV-7D)已經啟動III期臨牀試驗,並完成首例受試者入組。公司研發的凍幹水痘減毒活疫苗(VZV-7D)接種後可刺激機體產生抗水痘-帶狀皰疹病毒(Varicella-ZosterVirus,VZV)的免疫力,用於預防水痘。本品使用的毒株為用反向遺傳學技術構建出毒力基因ORF7表達缺陷的重組水痘-帶狀皰疹病毒株,本毒株既不感染皮膚引發水痘,也不潛伏神經再活化而產生帶狀皰疹,具有更好的安全性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account